期刊文献+

北京市30~59岁人群代谢异常的聚集与2型糖尿病的关系分析

The Aggregation of Metabolic Disorders and Type 2 Diabetes among 30-59 Year Old Population
下载PDF
导出
摘要 目的 分析中青年人代谢异常的聚集与 2型糖尿病 (DM )的关系。方法 横断面调查法调查北京市年龄3 0~ 5 9岁的中年人 60 2 9名 ,按空腹血糖≥ 7 0mmol/L的标准诊断DM。结果 各项代谢指标的年龄调整均数糖尿病组均较非糖尿病组高 (高密度脂蛋白胆固醇低 ) ;Logistic回归分析结果显示 ,有 4个代谢指标 ,包括体重指数 (BMI)、腰围、甘油三酯 (TG)、收缩压 (SBP) ,以及年龄与DM独立相关 ,OR (95 %CI)分别为 1 11(1 0 3~ 1 19) ,1 2 1(1 0 5~ 1 3 9) ,1 0 3 (1 0 2~ 1 0 4) ,1 2 3 (1 11~ 1 3 6)和 1 3 0 (1 14~ 1 49) ;调整年龄后 ,任 1、 2、 3、 4个上述代谢指标异常的聚集所对应的OR逐渐增大 ,各为 6 15~ 6 8、 8 5 8~ 12 69、 15 76~ 2 7 63和 3 5 5 2 ;几乎所有有显著意义的聚集组合均包括超重肥胖。结论 代谢异常聚集与DM密切相关 ,而人群中最危险的组合是包括肥胖的组合 ,控制代谢异常 。 Objective To analyze the relationship between the aggregation of metabolic disorders and type 2 diabetes(DM)among the young and middle-aged people Methods Cross sectional study was carried out in a sample of 6029(30-59 year old)in Beijing urban area The diagnostic criteria for DM is fasting glucose≥7 0 mmol/L Results The age-adjusted means of metabolic factors in DM group were higher than its counterparts(HDL lower) Multivariate Logistic regression model showed there were 4 metabolic factors including BMI,waist,triglycerides(TG),and systolic blood pressure(SBP),plus variable age independently associated with the risk of DM,with OR(95% CI)being 1 11(1 03-1 19)、1 21(1 05-1 39)、1 03(1 02-1 04)、1 23(1 11-1 36)and 1 30(1 14-1 49),respectively After adjusted for age,the OR for any 1,2,3,or 4 clusters of above metabolic disorders increased dramatically,with the OR being 6 15-6 80、8 58-12 69、15 76-27 63 and 35 52,respectively Almost all of the statistically significant clusters included overweight and obesity Conclusion The cluster of metabolic disorders is closely related to the risk of diabetes,therefore,multi-factor especially overweight and obesity intervention is suggested for DM earlier control
出处 《中国预防医学杂志》 CAS 2003年第1期5-8,共4页 Chinese Preventive Medicine
基金 国家"九五"科技攻关基金资助项目(2 0 0 1BA70 2B0 1 )
关键词 北京 30-59岁人群 代谢异常 聚集 2型糖尿病 Young and middle-aged people Type 2 diabetes Metabolic disorders
  • 相关文献

参考文献10

  • 1Stern MP, Morales PA, Valdez RA, et al. Predicting Diabetes: moving beyond impaired glucose tolerance. Diabetes, 1993, 42: 706 -714.
  • 2Boyko EJ, Courten MD, Zimmet PZ, et al. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance. Diabetes Care, 2000, 23:1242-1248.
  • 3Mykkanen L, Kuusisto J, Pyorala K, et al. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent)diabetes mellitus in elderly subjects. Diabetologia, 1993, 36: 553 -559.
  • 4全国高胆固醇血症控制状况多中心研究协作组.高胆固醇血症临床控制状况多中心协作研究——达标率及影响因素[J].中华心血管病杂志,2002,30(2):109-114. 被引量:176
  • 5国际生命科学学会中国办事处中国肥胖问题工作组联合数据汇总分析协作组.中国成人体质指数分类的推荐意见简介[J].中华预防医学杂志,2001,35(5):349-350. 被引量:1034
  • 6Haffner SM,Valdez RA,Hazuda HP,et al.Prospective analysis of the insulin-resistance syndrome(Syndrome X).Diabetes,1992,41:715-722.
  • 7李光伟,陈燕燕,张景玲,王金平,郑辉,姜亚云,胡英华.胰岛素抵抗是糖耐量正常人群糖耐量恶化的最重要危险因素[J].中华内分泌代谢杂志,2000,16(2):74-77. 被引量:64
  • 8Meigs JB, D' Agostino RB, Wilson PWF, et al. Risk variables clustering in the insulin resistance syndrome -the framingham offspring study. Diabetes, 1997, 46:1594-1600.
  • 9Chen W, Srinivasan SR, Elkasabany A, et al. Cardiovascular risk factors clustering features of insulin resistance sydrome (Syndrome X)in a biracial ( Black -White) population of children adolescents, and adults: the bogalusa heart study, Am J Epidemiol, 1999, 150:667-674.
  • 10Boyko EJ, Fujimoto WF, Leonetti DL, Visceral adiposity and risk of type 2 diabetes, a prospective study among Japanese Americans. Diabetes Care, 2000, 23:465-471.

二级参考文献21

  • 1Slamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol a nd risk of premature death from coronary heart disease continuous and graded ? F indings in 356,222 primary screenees of the Multiple Risk Factor Intervention Tr ial (MRFIT). JAMA, 1986,256:2823-2828.
  • 2Castelli WP, Garrison RJ,Wilson PwF, et al. Incidence of coronary heart disea se and lipoprotein cholesterol levels: the Framing ham Study. JAMA, 1986, 256:28 35-2838.
  • 3Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S).Lancet,1994,344:1383 -1389.
  • 4Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary- prevention t ri al with gemfibrozil in middle-aged men with dislipidemia. Safety of treatment ,c hages in risk factors, and incidence of coronary heart disease. N Engl J Med, 1 987,317:1237-1245.
  • 5Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease wit h pravastatin in men with hypercholesterolemia. West of Scotland Coronary Preven tion Study Group. N Engl J Med,1995,333:1301-1307.
  • 6Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary e v ents with lovastatin in men and women with average cholesterol levels: results o f AFCAPS/TexCAPS. Air Force/Texas Coronary Artherosclerosis Prevention Study. JAMA .1998;279:1615-1622.
  • 7Summary of the second report of the National Cholesterol Education Program (NC EP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholestero l in Adults ( Adult Treatment Panel II Report). JAMA, 1993, 269:3015-3023.
  • 8Report of the National Cholesterol Education Program Expert Panel on Detection , Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Pan el. Arch Intern Med, 1998, 148:36-69.
  • 90 Pearson TA, Laurora I, Chu H, et al. The lipid treatment assessment project (L -TAP):a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein choles terol goals. Arch Intern Med, 2000, 160:459-467.
  • 10方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献1271

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部